A DEEP TECH COMPANY PROVIDING TECHNOLOGICAL SOLUTIONS TO THE GLOBAL MARKET
IP3T has a diverse portfolio of Intellectual Property (IP) for products and technologies developed in house, to solve substantial scientific or engineering challenges.
IP3T development portfolio includes granted patents, patent applications and trade secret technologies across multiple sectors such as but not limited to: Packaging & Global Supply Chains, Safety & Environment, Regulatory & Analytical, Military & Aerospace and Healthcare & Pharmaceutical.
Highlights of the current portfolio include:
HIPPOPAK – wide neck reclosable carton. A major advance in the safe transportation and storage of semisolid, solid and viscous consumer products. A 90% reduction in raw material transport costs, fully recyclable, can be produced from recycled material and results in a reduction of global food waste.
RECHECKA – quality assurance system. A technology for in-situ QA & Brand protection to identify and verify high volume products through non-destructive, in-situ confirmation, in a fast, cost effective and functional way.
PATHOSTOP – combined antibacterial and antiviral additive. Kills up to 99.99% of infectious pathogens within 30 minutes, including SARS-CoV-2, active for over 10 years. A point of use additive for any type or brand of paint (light and dark colours), and an in-factory additive for use in plastics, composites and polymeric articles.
INSUHEDRA – extreme high temperature insulation. A rigid sandwich material, designed as an interlocking building block system with exceptional insulation properties and a thermal barrier in excess of 1980°C / 3600°F.
SKOSHMARK – covert nano barcode. – A unique special signature which is bespoke to an item and allows in-situ identification and verification.
SPECIDENT – analytical identification system. A long-range scanning system to confirm a technical specification of an item and or surface.
AIVIBA – pre-clinical anti-infective pharmaceutical. An orphan designated drug candidate which demonstrates broad spectrum organism susceptibility in vitro; including highly infectious organisms identified by the FDA MCM program.
IP3T engage in a continuous process of origination, optimization and out-licensing of its products and technologies and does not undertake contract work for other companies.
Head Office:
IP3 TECHNOLOGIES INC. 708 Main Street, 10th Floor, Houston, TX 77002
email: [email protected]
UK Office:
IP3 SERVICES LIMITED IP3 Offices, Yanworth, Cheltenham, GL54 3LQ
email: [email protected]